Cybin to participate in the h.c. wainwright 6th annual neuro perspectives conference

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that doug drysdale, cybin's chief executive officer, will participate in a virtual fireside chat at the h.c. wainwright 6th annual neuro perspectives conference, taking place june 16-17, 2025. mr. drysdale'.
CYBN Ratings Summary
CYBN Quant Ranking